USP39 reduces BRCA1 methylation to promote mitochondrial biogenesis and lower drug sensitivity in ovarian cancer through deubiquitinating ZC3H18
{{output}}
Ovarian cancer (OV) is a leading cause of mortality related to gynecological malignancies. Chemoresistance represents a major clinical obstacle. Carboplatin (CBP) is a first-line chemotherapeutic agent widely used for ovarian cancer treatment. Meanwhile, Zinc ... ...
